Insider sale
CHEMOMAB THERAPEUTICS LTD.
$1.01M
500K shares
What this filing means
ORBIMED ISRAEL GP LTD. plans to sell 500K shares of CHEMOMAB THERAPEUTICS LTD. valued at approximately $1.01M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2024ACC: 0000947871-24-000751
10% Owner
Since Mar 2021
500K
Shares to sell
$1.01M
Approx. market value
500K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Merger
N/A
3/16/2021
500KTotal acquired500K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2021 | Merger N/A | 500K | — |
| Total | 500K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
500K
Market value
$1.01M
9/12/2024
Total
Units
500K
Value
$1.01M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/12/2024 | 500K | $1.01M | Nasdaq Stock Market | Planned |
| Total | 500K | $1.01M | ||